Home Purigen Biosystems

Purigen Biosystems

In operation
Series B
Biotechnology Company

Basic Information

Purigen Biosystems' transformation platform offers a solution without manual intervention for extracting, enriching, and quantifying DNA and RNA from biological samples. The company's patented method uses isotachophoresis (ITP), an electric field-driven technology for purifying, focusing, and/or separating species. The application of ITP for purifying and quantifying nucleic acids in complex biological samples was pioneered by Purigen co-founder and Stanford University professor Juan G. Santiago. Purigen’s system is compatible with a range of sample types, including mammalian cells, FFPE and FNA tissue biopsies, plasma, blood, and buccal swabs.
Purigen Biosystems, Inc.
California,United States of America
15~50 people
January 01, 2012
info@purigenbio.com